デフォルト表紙
市場調査レポート
商品コード
1507218

リアルワールドエビデンス（RWE）アプリケーション向けゲノムデータセット市場、シェア、規模、動向、産業分析レポート：用途別、支出別、エンドユーザー別、ゲノムデータタイプ別、患者記録別、データタイプ別、地域別、セグメント別予測、2024年～2032年

Genomic Data Set for Real World Evidence (RWE) Applications Market Share, Size, Trends, Industry Analysis Report, By Application; By Spend; By End-Users; By Genomic Data Type; By Patient Records; By Data Type; By Region; Segment Forecast, 2024 - 2032

出版日
ページ情報
英文 116 Pages
納期
即日から翌営業日
カスタマイズ可能
リアルワールドエビデンス（RWE）アプリケーション向けゲノムデータセット市場、シェア、規模、動向、産業分析レポート：用途別、支出別、エンドユーザー別、ゲノムデータタイプ別、患者記録別、データタイプ別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年06月01日
発行: Polaris Market Research
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のリアルワールドエビデンス（RWE）アプリケーション用ゲノムデータセット市場規模は2032年までに17億460万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

世界のリアルワールドエビデンス（RWE）アプリケーション用ゲノムデータセット市場は、高度なゲノム解析、ヘルスケア分析、デジタル技術の融合が原動力となり、著しい成長と革新が進んでいます。このダイナミックな市場は、疾患の遺伝的基盤に関する重要な洞察を提供し、患者の個別ケアを促進することで、ヘルスケア研究、治療、転帰に革命をもたらす可能性を秘めています。主な成長要因は、精密医療の採用が拡大していることです。ゲノムデータを活用して標的治療や診断ツールを開発することで、より効果的な治療、副作用の低減、患者の転帰の改善につながります。

市場を推進するもう1つの重要な要因は、集団健康管理への注目が高まっていることです。ゲノムデータは、集団内の遺伝的変異に関する貴重な洞察に貢献し、疾病予防、早期発見、的を絞った介入のための事前対策を可能にします。大規模なゲノムデータセットにより、公衆衛生機関は高リスク集団を特定し、オーダーメイドのスクリーニングプログラムを開発し、効果的な公衆衛生戦略を実施することができます。しかし、この市場は、機密性の高い遺伝子情報に関連するプライバシーへの懸念やセキュリティ問題などの課題に直面しています。これらの懸念に対処し、ゲノムデータの収集と解析に関与する患者、研究者、利害関係者に信頼を与えるためには、規制の枠組みと強固なデータ保護対策が不可欠です。

その変革の可能性にもかかわらず、倫理的配慮が、RWE応用のために世界なゲノムデータセットを十分に活用する上での足かせとなっています。データの利用可能性とプライバシー保護のバランスを取るには、責任あるデータ利用、インフォームド・コンセント、透明性のあるデータ共有の実践を確実にするための強固なガバナンスの枠組み、基準、プロトコルの確立が必要です。個人の権利を守りつつ、社会からの信頼を強化し、ゲノムデータへの公平なアクセスを確保することは、この分野の倫理的かつ持続可能な成長にとって極めて重要です。

リアルワールドエビデンス（RWE）アプリケーション用ゲノムデータセット市場レポートハイライト

腫瘍学がReal World Evidence向けゲノムデータセット市場を独占し、個別化されたがん介入と治療精度のためにゲノムの知見を活用しています。

サービス/CROのような収益が予測期間中RWE向けゲノムデータセット市場を牽引し、個別化医療の進歩と市場成長を促進

北米は、先進的なインフラ、強固な研究開発、ゲノム医療への取り組みにより、2022年の世界市場を独占し、リアルワールドエビデンスの応用を形成しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のリアルワールドエビデンス（RWE）アプリケーション向けゲノムデータセットの市場分析

  • リアルワールドエビデンス（RWE）アプリケーション向けゲノムデータセット-業界スナップショット
  • リアルワールドエビデンス（RWE）アプリケーション向けゲノムデータセットの市場力学
    • 促進要因と機会
      • ゲノム技術の進歩
      • 精密医療とパーソナライズされたヘルスケア
    • 抑制要因と課題
      • データのプライバシーとセキュリティに関する懸念
  • ポーターのファイブフォース分析
  • PESTLE分析
  • リアルワールドエビデンス（RWE）アプリケーション向けゲノムデータセット業界動向
  • COVID-19の影響分析

第5章 世界のリアルワールドエビデンス（RWE）アプリケーション向けゲノムデータセット市場：ネットワークモデル別

  • 主な調査結果
  • イントロダクション
  • 腫瘍学
  • 心臓血管
  • 神経学
  • 免疫学
  • その他

第6章 世界のリアルワールドエビデンス（RWE）アプリケーション向けゲノムデータセット市場：支出別

  • 主な調査結果
  • イントロダクション
  • RWゲノムデータ
  • RWソフトウェア
  • サービス/CROのような収益
  • データ生成
  • その他

第7章 世界のリアルワールドエビデンス（RWE）アプリケーション向けゲノムデータセット市場：データタイパー別

  • 主な調査結果
  • イントロダクション
  • バイオ医薬品
  • その他のセグメント

第8章 世界のリアルワールドエビデンス（RWE）アプリケーション向けゲノムデータセット市場：ゲノムデータタイプ別

  • 主な調査結果
  • イントロダクション
  • 完全オミクス配列データ
  • その他

第9章 世界のリアルワールドエビデンス（RWE）アプリケーション向けゲノムデータセット市場：患者記録別

  • 主な調査結果
  • イントロダクション
  • 個別化
  • 集計

第10章 世界のリアルワールドエビデンス（RWE）アプリケーション向けゲノムデータセット市場：データタイプ別

  • 主な調査結果
  • イントロダクション
  • DNA（遺伝）
  • RNA（トランスクリプトーム）
  • タンパク質（プロテオーム）
  • 代謝物（代謝物）
  • その他

第11章 世界のリアルワールドエビデンス（RWE）アプリケーション向けゲノムデータセット市場：地域

  • 主な調査結果
  • イントロダクション
    • リアルワールドエビデンス（RWE）アプリケーション向けゲノムデータセット市場評価：地域別、2019-2032年
  • 北米
    • 北米：ネットワークモデル別、2019-2032年
    • 北米：ゲノムデータタイプ別、2019-2032年
    • 北米：支出別、2019-2032年
    • 北米：患者記録別、2019-2032年
    • 北米：データタイパー別、2019-2032年
    • 北米：データタイプ別、2019-2032年
    • 米国
    • カナダ
  • 欧州
    • 欧州：ネットワークモデル別、2019-2032年
    • 欧州：ゲノムデータタイプ別、2019-2032年
    • 欧州：支出別、2019-2032年
    • 欧州：患者記録別、2019-2032年
    • 欧州：データタイパー別、2019-2032年
    • 欧州：データタイプ別、2019-2032
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
  • アジア太平洋地域
    • アジア太平洋地域：ネットワークモデル別、2019-2032年
    • アジア太平洋地域：ゲノムデータタイプ別、2019-2032年
    • アジア太平洋地域：支出別、2019-2032年
    • アジア太平洋地域：患者記録別、2019-2032年
    • アジア太平洋地域：データタイパー別、2019-2032年
    • アジア太平洋地域：データタイプ別、2019-2032
    • 中国
    • インド
    • 日本
    • マレーシア
    • インドネシア
    • 韓国
  • 中東・アフリカ
    • 中東・アフリカ：ネットワークモデル別、2019-2032年
    • 中東・アフリカ：ゲノムデータタイプ別、2019-2032年
    • 中東・アフリカ：支出別、2019-2032年
    • 中東・アフリカ：患者記録別、2019-2032年
    • 中東・アフリカ：データタイパー別、2019-2032年
    • 中東・アフリカ：データタイプ別、2019-2032
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：ネットワークモデル別、2019-2032年
    • ラテンアメリカ：ゲノムデータタイプ別、2019-2032年
    • ラテンアメリカ：支出別、2019-2032年
    • ラテンアメリカ：患者記録別、2019-2032年
    • ラテンアメリカ：データタイパー別、2019-2032年
    • ラテンアメリカ：データタイプ別、2019-2032
    • メキシコ
    • ブラジル
    • アルゼンチン

第12章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第13章 企業プロファイル

  • Caris Life Sciences
  • Foundation Medicine, Inc
  • Guardant Health
  • HealthVerity, Inc
  • Invitae Corporation
  • IQVIA Inc
  • Komodo Health, Inc
  • LabCorp
  • Myriad Genetics Inc
  • Natera, Inc
  • Ovation.io
  • TEMPUS
図表

List of Tables

  • Table 1 Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, by Region, 2019-2032 (USD Million)
  • Table 2 Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, by Region, 2019-2032 (USD Million)
  • Table 3 Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, by Region, 2019-2032 (USD Million)
  • Table 4 Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, by Region, 2019-2032 (USD Million)
  • Table 5 Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, by Region, 2019-2032 (USD Million)
  • Table 6 Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, by Region, 2019-2032 (USD Million)
  • Table 7 North America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 8 North America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 9 North America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 10 North America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 11 North America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 12 North America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 13 U.S.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 14 U.S.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 15 U.S.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 16 U.S.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 17 U.S.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 18 U.S.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 19 Canada: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 20 Canada: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 21 Canada: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 22 Canada: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 23 Canada: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 24 Canada: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 25 Europe: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 26 Europe: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 27 Europe: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 28 Europe: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 29 Europe: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 30 Europe: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 31 Germany: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 32 Germany: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 33 Germany: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 34 Germany: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 35 Germany: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 36 Germany: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 37 France: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 38 France: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 39 France: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 40 France: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 41 France: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 42 France: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 43 UK: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 44 UK: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 45 UK: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 46 UK: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 47 UK: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 48 UK: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 49 Italy: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 50 Italy: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 51 Italy: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 52 Italy: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 53 Italy: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 54 Italy: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 55 Netherlands: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 56 Netherlands: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 57 Netherlands: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 58 Netherlands: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 59 Netherlands: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 60 Netherlands: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 61 Spain: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 62 Spain: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 63 Spain: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 64 Spain: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 65 Spain: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 66 Spain: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 67 Russia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 68 Russia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 69 Russia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 70 Russia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 71 Russia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 72 Russia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 73 Asia Pacific: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 74 Asia Pacific: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 75 Asia Pacific: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 76 Asia Pacific: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 77 Asia Pacific: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 78 Asia Pacific: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 79 China: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 80 China: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 81 China: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 82 China: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 83 China: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 84 China: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 85 Japan: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 86 Japan: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 87 Japan: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 88 Japan: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 89 Japan: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 90 Japan: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 91 India: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 92 India: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 93 India: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 94 India: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 95 India: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 96 India: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 97 Indonesia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 98 Indonesia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 99 Indonesia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 100 Indonesia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 101 Indonesia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 102 Indonesia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 103 Malaysia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 104 Malaysia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 105 Malaysia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 106 Malaysia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 107 Malaysia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 108 Malaysia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 109 South Korea: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 110 South Korea: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 111 South Korea: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 112 South Korea: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 113 South Korea: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 114 South Korea: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 115 Latin America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 116 Latin America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 117 Latin America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 118 Latin America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 119 Latin America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 120 Latin America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 121 Brazil: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 122 Brazil: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 123 Brazil: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 124 Brazil: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 125 Brazil: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 126 Brazil: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 127 Mexico: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 128 Mexico: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 129 Mexico: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 130 Mexico: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 131 Mexico: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 132 Mexico: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 133 Argentina: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 134 Argentina: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 135 Argentina: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 136 Argentina: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 137 Argentina: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 138 Argentina: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 139 Middle East & Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 140 Middle East & Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 141 Middle East & Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 142 Middle East & Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 143 Middle East & Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 144 Middle East & Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 145 UAE: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 146 UAE: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 147 UAE: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 148 UAE: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 149 UAE: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 150 UAE: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 151 Saudi Arabia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 152 Saudi Arabia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 153 Saudi Arabia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 154 Saudi Arabia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 155 Saudi Arabia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 156 Saudi Arabia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 157 South Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 158 South Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 159 South Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 160 South Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 161 South Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 162 South Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • Table 163 Israel: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
  • Table 164 Israel: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • Table 165 Israel: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • Table 166 Israel: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • Table 167 Israel: Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2019-2032 (USD Million)
  • Table 168 Israel: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Data typers
  • Figure 7. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2022 & 2032 (USD Million)
  • Figure 8. Market by Network Model
  • Figure 9. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2022 & 2032 (USD Million)
  • Figure 10. Market by Spend
  • Figure 11. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2022 & 2032 (USD Million)
  • Figure 12. Market by Genomic Data Type
  • Figure 13. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2022 & 2032 (USD Million)
  • Figure 14. Market by End User
  • Figure 15. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by End User, 2022 & 2032 (USD Million)
  • Figure 16. Market by Patient Records
  • Figure 17. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2022 & 2032 (USD Million)
  • Figure 18. Genomic Data Set for Real World Evidence (RWE) Applications Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 19. Strategic Analysis - Genomic Data Set for Real World Evidence (RWE) Applications Market
目次
Product Code: PM4969

The global genomic data set for real-world evidence (RWE) applications market size is expected to reach USD 1,704.60 million by 2032, according to a new study by Polaris Market Research. The report "Genomic Data Set for Real World Evidence (RWE) Applications Market Share, Size, Trends, Industry Analysis Report, By Application; By Spend; By End-Users; By Genomic Data Type; By Patient Records; By Data Type; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global genomic data set for the Real-World Evidence (RWE) applications market is undergoing significant growth and innovation, driven by the convergence of advanced genomics, healthcare analytics, and digital technologies. This dynamic market has the potential to revolutionize healthcare research, treatment, and outcomes by offering critical insights into the genetic basis of diseases and facilitating personalized patient care. A key growth driver is the escalating adoption of precision medicine, wherein genomic data is leveraged to develop targeted therapies and diagnostic tools, leading to more effective treatments, reduced adverse reactions, and improved patient outcomes.

Another pivotal factor propelling the market is the increasing focus on population health management. Genomic data contributes valuable insights into genetic variations within populations, enabling proactive measures for disease prevention, early detection, and targeted interventions. Large-scale genomic datasets empower public health organizations to identify high-risk populations, develop tailored screening programs, and implement effective public health strategies. However, the market faces challenges such as privacy concerns and security issues associated with sensitive genetic information. Regulatory frameworks and robust data protection measures are essential to address these concerns, instilling confidence in patients, researchers, and stakeholders involved in genomic data collection and analysis.

Despite its transformative potential, ethical considerations pose a restraint in fully harnessing the global genomic data set for RWE applications. Balancing data accessibility with privacy protection requires the establishment of robust governance frameworks, standards, and protocols to ensure responsible data use, informed consent, and transparent data-sharing practices. Strengthening public trust and ensuring equitable access to genomic data while safeguarding individual rights are crucial for the ethical and sustainable growth of this field.

Genomic Data Set for Real World Evidence (RWE) Applications Market Report Highlights

Oncology dominates the Genomic Data Set for the Real World Evidence market and leverages genomic insights for personalized cancer interventions and treatment precision.

Services/CRO-like revenues drive Genomic Data Set for the RWE market over a forecasted period, fostering personalized medicine advancements and market growth.

North America dominated the global market in 2022 due to advanced infrastructure, robust R&D, and genomic medicine initiatives, shaping real-world evidence applications.

The global key market players include TEMPUS, Guardant Health, Foundation Medicine, Inc., IQVIA Inc., HealthVerity, Inc., Komodo Health, Inc., Caris Life Sciences, LabCorp, Invitae Corporation, Myriad Genetics Inc., Natera, Inc., Ovation.io

Polaris Market Research has segmented the Genomic Data Set for Real World Evidence (RWE) Applications market report based on application, spend, end-users, genomic data type, patient records, data type, and region:

Genomic Data Set for Real World Evidence (RWE) Applications, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Oncology
  • Cardiovascular
  • Neurology
  • Immunology
  • Others

Genomic Data Set for Real World Evidence (RWE) Applications, Spend Outlook (Revenue - USD Million, 2019 - 2032)

  • RW genomic data
  • RW software
  • Services/ CRO-like revenues
  • Data Generation
  • Others

Genomic Data Set for Real World Evidence (RWE) Applications, End-Users Outlook (Revenue - USD Million, 2019 - 2032)

  • Biopharma
  • Other Segments

Genomic Data Set for Real World Evidence (RWE) Applications, Genomic Data Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Full 'omic sequence data
  • Others

Genomic Data Set for Real World Evidence (RWE) Applications, Patient Records Outlook (Revenue - USD Million, 2019 - 2032)

  • Individualized
  • Aggregate

Genomic Data Set for Real World Evidence (RWE) Applications, Data Type Outlook (Revenue - USD Million, 2019 - 2032)

  • DNA (genetic)
  • RNA (transcriptome)
  • Protein (proteome)
  • Metabolite (metabolite)
  • Others

Genomic Data Set for Real World Evidence (RWE) Applications, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Austria
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Genomic Data Set for Real World Evidence (RWE) Applications Market Insights

  • 4.1. Genomic Data Set for Real World Evidence (RWE) Applications - Industry Snapshot
  • 4.2. Genomic Data Set for Real World Evidence (RWE) Applications Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in genomic technologies
      • 4.2.1.2. Precision medicine and personalized healthcare
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Data privacy and security concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Genomic Data Set for Real World Evidence (RWE) Applications Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
  • 5.3. Oncology
    • 5.3.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Oncology, by Region, 2019-2032 (USD Million)
  • 5.4. Cardiovascular
    • 5.4.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Cardiovascular, by Region, 2019-2032 (USD Million)
  • 5.5. Neurology
    • 5.5.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Neurology, by Region, 2019-2032 (USD Million)
  • 5.6. Immunology
    • 5.6.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Immunology, by Region, 2019-2032 (USD Million)
  • 5.7. Others
    • 5.7.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
  • 6.3. RW genomic data
    • 6.3.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by RW genomic data, by Region, 2019-2032 (USD Million)
  • 6.4. RW software
    • 6.4.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by RW software, by Region, 2019-2032 (USD Million)
  • 6.5. Services/ CRO-like revenues
    • 6.5.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Services/ CRO-like revenues, by Region, 2019-2032 (USD Million)
  • 6.6. Data Generation
    • 6.6.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data Generation, by Region, 2019-2032 (USD Million)
  • 6.7. Others
    • 6.7.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • 7.3. Biopharma
    • 7.3.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Biopharma, by Region, 2019-2032 (USD Million)
  • 7.4. Other Segments
    • 7.4.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Other Segments, by Region, 2019-2032 (USD Million)

8. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
  • 8.3. Full 'omic sequence data
    • 8.3.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Full 'omic sequence data, by Region, 2019-2032 (USD Million)
  • 8.4. Others
    • 8.4.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Others, by Region, 2019-2032 (USD Million)

9. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
  • 9.3. Individualized
    • 9.3.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Individualized, by Region, 2019-2032 (USD Million)
  • 9.4. Aggregate
    • 9.4.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Aggregate, by Region, 2019-2032 (USD Million)

10. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
  • 10.3. DNA (genetic)
    • 10.3.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by DNA (genetic), by Region, 2019-2032 (USD Million)
  • 10.4. RNA (transcriptome)
    • 10.4.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by RNA (transcriptome), by Region, 2019-2032 (USD Million)
  • 10.5. Protein (proteome)
    • 10.5.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Protein (proteome), by Region, 2019-2032 (USD Million)
  • 10.6. Metabolite (metabolite)
    • 10.6.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Metabolite (metabolite), by Region, 2019-2032 (USD Million)
  • 10.7. Others
    • 10.7.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Others, by Region, 2019-2032 (USD Million)

11. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Geography

  • 11.1. Key findings
  • 11.2. Introduction
    • 11.2.1. Genomic Data Set for Real World Evidence (RWE) Applications Market Assessment, By Geography, 2019-2032 (USD Million)
  • 11.3. Genomic Data Set for Real World Evidence (RWE) Applications Market - North America
    • 11.3.1. North America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
    • 11.3.2. North America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
    • 11.3.3. North America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
    • 11.3.4. North America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
    • 11.3.5. North America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
    • 11.3.6. North America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.3.7. Genomic Data Set for Real World Evidence (RWE) Applications Market - U.S.
      • 11.3.7.1. U.S.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.3.7.2. U.S.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.3.7.3. U.S.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.3.7.4. U.S.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.3.7.5. U.S.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.3.7.6. U.S.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.3.8. Genomic Data Set for Real World Evidence (RWE) Applications Market - Canada
      • 11.3.8.1. Canada: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.3.8.2. Canada.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.3.8.3. Canada: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.3.8.4. Canada: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.3.8.5. Canada: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.3.8.6. Canada: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
  • 11.4. Genomic Data Set for Real World Evidence (RWE) Applications Market - Europe
    • 11.4.1. Europe: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
    • 11.4.2. Europe.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
    • 11.4.3. Europe: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
    • 11.4.4. Europe: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
    • 11.4.5. Europe: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
    • 11.4.6. Europe: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.4.7. Genomic Data Set for Real World Evidence (RWE) Applications Market - UK
      • 11.4.7.1. UK: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.4.7.2. UK.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.4.7.3. UK: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.4.7.4. UK: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.4.7.5. UK: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.4.7.6. UK: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.4.8. Genomic Data Set for Real World Evidence (RWE) Applications Market - France
      • 11.4.8.1. France: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.4.8.2. France.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.4.8.3. France: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.4.8.4. France: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.4.8.5. France: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.4.8.6. France: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.4.9. Genomic Data Set for Real World Evidence (RWE) Applications Market - Germany
      • 11.4.9.1. Germany: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.4.9.2. Germany.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.4.9.3. Germany: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.4.9.4. Germany: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.4.9.5. Germany: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.4.9.6. Germany: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.4.10. Genomic Data Set for Real World Evidence (RWE) Applications Market - Italy
      • 11.4.10.1. Italy: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.4.10.2. Italy.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.4.10.3. Italy: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.4.10.4. Italy: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.4.10.5. Italy: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.4.10.6. Italy: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.4.11. Genomic Data Set for Real World Evidence (RWE) Applications Market - Spain
      • 11.4.11.1. Spain: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.4.11.2. Spain.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.4.11.3. Spain: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.4.11.4. Spain: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.4.11.5. Spain: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.4.11.6. Spain: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.4.12. Genomic Data Set for Real World Evidence (RWE) Applications Market - Netherlands
      • 11.4.12.1. Netherlands: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.4.12.2. Netherlands.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.4.12.3. Netherlands: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.4.12.4. Netherlands: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.4.12.5. Netherlands: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.4.12.6. Netherlands: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.4.13. Genomic Data Set for Real World Evidence (RWE) Applications Market - Russia
      • 11.4.13.1. Russia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.4.13.2. Russia.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.4.13.3. Russia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.4.13.4. Russia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.4.13.5. Russia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.4.13.6. Russia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
  • 11.5. Genomic Data Set for Real World Evidence (RWE) Applications Market - Asia Pacific
    • 11.5.1. Asia Pacific: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
    • 11.5.2. Asia Pacific.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
    • 11.5.3. Asia Pacific: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
    • 11.5.4. Asia Pacific: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
    • 11.5.5. Asia Pacific: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
    • 11.5.6. Asia Pacific: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.5.7. Genomic Data Set for Real World Evidence (RWE) Applications Market - China
      • 11.5.7.1. China: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.5.7.2. China.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.5.7.3. China: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.5.7.4. China: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.5.7.5. China: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.5.7.6. China: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.5.8. Genomic Data Set for Real World Evidence (RWE) Applications Market - India
      • 11.5.8.1. India: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.5.8.2. India.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.5.8.3. India: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.5.8.4. India: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.5.8.5. India: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.5.8.6. India: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.5.9. Genomic Data Set for Real World Evidence (RWE) Applications Market - Japan
      • 11.5.9.1. Japan: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.5.9.2. Japan.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.5.9.3. Japan: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.5.9.4. Japan: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.5.9.5. Japan: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.5.9.6. Japan: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.5.10. Genomic Data Set for Real World Evidence (RWE) Applications Market - Malaysia
      • 11.5.10.1. Malaysia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.5.10.2. Malaysia.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.5.10.3. Malaysia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.5.10.4. Malaysia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.5.10.5. Malaysia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.5.10.6. Malaysia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.5.11. Genomic Data Set for Real World Evidence (RWE) Applications Market - Indonesia
      • 11.5.11.1. Indonesia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.5.11.2. Indonesia.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.5.11.3. Indonesia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.5.11.4. Indonesia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.5.11.5. Indonesia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.5.11.6. Indonesia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.5.12. Genomic Data Set for Real World Evidence (RWE) Applications Market - South Korea
      • 11.5.12.1. South Korea: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.5.12.2. South Korea.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.5.12.3. South Korea: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.5.12.4. South Korea: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.5.12.5. South Korea: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.5.12.6. South Korea: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
  • 11.6. Genomic Data Set for Real World Evidence (RWE) Applications Market - Middle East & Africa
    • 11.6.1. Middle East & Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
    • 11.6.2. Middle East & Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
    • 11.6.3. Middle East & Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
    • 11.6.4. Middle East & Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
    • 11.6.5. Middle East & Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
    • 11.6.6. Middle East & Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.6.7. Genomic Data Set for Real World Evidence (RWE) Applications Market - Saudi Arabia
      • 11.6.7.1. Saudi Arabia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.6.7.2. Saudi Arabia.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.6.7.3. Saudi Arabia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.6.7.4. Saudi Arabia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.6.7.5. Saudi Arabia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.6.7.6. Saudi Arabia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.6.8. Genomic Data Set for Real World Evidence (RWE) Applications Market - UAE
      • 11.6.8.1. UAE: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.6.8.2. UAE.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.6.8.3. UAE: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.6.8.4. UAE: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.6.8.5. UAE: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.6.8.6. UAE: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.6.9. Genomic Data Set for Real World Evidence (RWE) Applications Market - Israel
      • 11.6.9.1. Israel: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.6.9.2. Israel.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.6.9.3. Israel: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.6.9.4. Israel: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.6.9.5. Israel: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.6.9.6. Israel: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.6.10. Genomic Data Set for Real World Evidence (RWE) Applications Market - South Africa
      • 11.6.10.1. South Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.6.10.2. South Africa.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.6.10.3. South Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.6.10.4. South Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.6.10.5. South Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.6.10.6. South Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
  • 11.7. Genomic Data Set for Real World Evidence (RWE) Applications Market - Latin America
    • 11.7.1. Latin America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
    • 11.7.2. Latin America.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
    • 11.7.3. Latin America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
    • 11.7.4. Latin America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
    • 11.7.5. Latin America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
    • 11.7.6. Latin America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.7.7. Genomic Data Set for Real World Evidence (RWE) Applications Market - Mexico
      • 11.7.7.1. Mexico: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.7.7.2. Mexico.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.7.7.3. Mexico: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.7.7.4. Mexico: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.7.7.5. Mexico: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.7.7.6. Mexico: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.7.8. Genomic Data Set for Real World Evidence (RWE) Applications Market - Brazil
      • 11.7.8.1. Brazil: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.7.8.2. Brazil.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.7.8.3. Brazil: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.7.8.4. Brazil: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.7.8.5. Brazil: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.7.8.6. Brazil: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
    • 11.7.9. Genomic Data Set for Real World Evidence (RWE) Applications Market - Argentina
      • 11.7.9.1. Argentina: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
      • 11.7.9.2. Argentina.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
      • 11.7.9.3. Argentina: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
      • 11.7.9.4. Argentina: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
      • 11.7.9.5. Argentina: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
      • 11.7.9.6. Argentina: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)

12. Competitive Landscape

  • 12.1. Expansion and Acquisition Analysis
    • 12.1.1. Expansion
    • 12.1.2. Acquisitions
  • 12.2. Partnerships/Collaborations/Agreements/Exhibitions

13. Company Profiles

  • 13.1. Caris Life Sciences
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Benchmarking
    • 13.1.4. Recent Development
  • 13.2. Foundation Medicine, Inc
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Benchmarking
    • 13.2.4. Recent Development
  • 13.3. Guardant Health
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Benchmarking
    • 13.3.4. Recent Development
  • 13.4. HealthVerity, Inc
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Benchmarking
    • 13.4.4. Recent Development
  • 13.5. Invitae Corporation
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Benchmarking
    • 13.5.4. Recent Development
  • 13.6. IQVIA Inc
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Benchmarking
    • 13.6.4. Recent Development
  • 13.7. Komodo Health, Inc
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Benchmarking
    • 13.7.4. Recent Development
  • 13.8. LabCorp
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Benchmarking
    • 13.8.4. Recent Development
  • 13.9. Myriad Genetics Inc
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Benchmarking
    • 13.9.4. Recent Development
  • 13.10. Natera, Inc
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Benchmarking
    • 13.10.4. Recent Development
  • 13.11. Ovation.io
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Benchmarking
    • 13.11.4. Recent Development
  • 13.12. TEMPUS
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Benchmarking
    • 13.12.4. Recent Development